RxSight, Inc. — Director's Dealing 2025

Sep 26, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2025-09-25

Reporting Person: Goldshleger Ilya (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-09-25	Common Stock	M	15096	$4.34	Acquired	57342	Direct
2025-09-25	Common Stock	M	8349	$4.13	Acquired	65691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-25	Stock Option (right to buy)	$4.34	M	5416	Disposed	2026-10-26	Common Stock (5416)	Direct
2025-09-25	Stock Option (right to buy)	$4.34	M	9680	Disposed	2027-03-13	Common Stock (9680)	Direct
2025-09-25	Stock Option (right to buy)	$4.13	M	8349	Disposed	2027-04-25	Common Stock (8349)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1372	Indirect